The lifetime risk for colorectal cancer is 1 in 23 men and 1 in 25 women. Detecting and diagnosing cancer is a critical step in managing a patient’s health as well as the multidisciplinary team where their care is discussed.

This is the second episode of a three part series on colorectal cancer.

This episode focuses on diagnosis.

Many thanks to Dr Tristan Rutland who helped organise this series.

This is the story of colorectal cancer (part 2).

Our special guests:

Dr Milan Bassan: gastroenterologist and Director of Endoscopy at Liverpool Hospital and returning guest

Dr Scott Mackenzie: surgeon and senior lecturer at the Liverpool Hospital and returning guest

Dr Tristan Rutland: lecturer, award winning anatomical pathologist for teaching and regular guest

This Medical Life podcast is available on all podcasting services and Spotify.

See omnystudio.com/listener for privacy information.

Colorectal cancer accounts for ~10% of all new cancer diagnoses. Fortunately, over the last three decades, the 5 year patient survival has increased from 56% to 71%. As with most cancers, the key to good outcomes is early detection. This is the first episode of a three part series on colorectal cancer. This episode focuses on screening.

Many thanks to Dr Tristan Rutland who helped organise this series.

This is the story of colorectal cancer (part 1).

Our special guests are:

Professor Ken Sikaris: chemical pathologists, Director of Chemical Pathology at Dorevitch Pathology and regular guest

Dr Milan Bassan: gastroenterologist and Director of Endoscopy at Liverpool Hospital and returning guest

Dr Tristan Rutland: lecturer, award winning anatomical pathologist for teaching and regular guest

This Medical Life podcast is available on all podcasting services and Spotify.

See omnystudio.com/listener for privacy information.

Troponin is a protein found in heart muscle that was a game changer when it came to diagnosing heart attacks and myocardial injury in the late 1990s. Three decades later, it is an invaluable test with widespread use throughout medicine.

Troponin assays are venturing into their 5th generation with high-sensitivity and Point-Of-Care (POC) devices. However, there are important exceptions, caveats and pitfalls for doctors to know.

This is the story of troponin.

Our special guest:

Our special guest is Dr Christina Trambas who is a chemical pathologist, Medical Director at St Vincent’s Pathology and chair of the Royal College of Pathologists of Australiasia (RCPA) Troponin Working Party.

This Medical Life podcast is available on all podcasting services and Spotify.

See omnystudio.com/listener for privacy information.